142 related articles for article (PubMed ID: 8844998)
1. Regulation of HIV-1 gene expression by NF-IL6.
Tesmer VM; Bina M
J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998
[TBL] [Abstract][Full Text] [Related]
2. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
Vlach J; Garcia A; Jacqué JM; Rodriguez MS; Michelson S; Virelizier JL
Virology; 1995 Apr; 208(2):753-61. PubMed ID: 7747447
[TBL] [Abstract][Full Text] [Related]
3. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals.
Tong-Starksen SE; Welsh TM; Peterlin BM
J Immunol; 1990 Dec; 145(12):4348-54. PubMed ID: 2258623
[TBL] [Abstract][Full Text] [Related]
4. NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1.
Tesmer VM; Rajadhyaksha A; Babin J; Bina M
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7298-302. PubMed ID: 8346247
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6.
Kashanchi F; Thompson J; Sadaie MR; Doniger J; Duvall J; Brady JN; Rosenthal LJ
Virology; 1994 May; 201(1):95-106. PubMed ID: 8178493
[TBL] [Abstract][Full Text] [Related]
6. The nuclear factor NF-IL6 activates human placental lactogen gene expression.
Stephanou A; Handwerger S
Biochem Biophys Res Commun; 1995 Jan; 206(1):215-22. PubMed ID: 7818522
[TBL] [Abstract][Full Text] [Related]
7. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain.
Trautwein C; Caelles C; van der Geer P; Hunter T; Karin M; Chojkier M
Nature; 1993 Aug; 364(6437):544-7. PubMed ID: 8336793
[TBL] [Abstract][Full Text] [Related]
8. cis-acting regulatory elements in the bovine immunodeficiency virus long terminal repeat.
Fong SE; Pallansch LA; Mikovits JA; Lackman-Smith CS; Ruscetti FW; Gonda MA
Virology; 1995 Jun; 209(2):604-14. PubMed ID: 7778292
[TBL] [Abstract][Full Text] [Related]
9. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
11. NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line.
Antoni BA; Rabson AB; Kinter A; Bodkin M; Poli G
Virology; 1994 Aug; 202(2):684-94. PubMed ID: 7913275
[TBL] [Abstract][Full Text] [Related]
12. NF kappa B upstream regulatory sequences of the HIV-1 LTR are involved in the inhibition of HIV-1 promoter activity by the NS proteins of autonomous parvoviruses H-1 and MVMp.
Faisst SR; Faisst S; Grangette C; Schlehofer JR; Rommelaere J
Virology; 1993 Dec; 197(2):770-3. PubMed ID: 8249299
[TBL] [Abstract][Full Text] [Related]
13. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid inhibits both the basal activity and phorbol ester-mediated activation of the HIV long terminal repeat promoter.
Towers G; Harris J; Lang G; Collins MK; Latchman DS
AIDS; 1995 Feb; 9(2):129-36. PubMed ID: 7718183
[TBL] [Abstract][Full Text] [Related]
15. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
Subler MA; Martin DW; Deb S
J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
[TBL] [Abstract][Full Text] [Related]
16. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements.
Desai-Yajnik V; Samuels HH
Mol Cell Biol; 1993 Aug; 13(8):5057-69. PubMed ID: 8393143
[TBL] [Abstract][Full Text] [Related]
17. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
[TBL] [Abstract][Full Text] [Related]
18. Activation of human immunodeficiency virus 1 gene expression by the src oncoprotein.
Dehbi M; Beaulieu S; Cohen EA; Bédard PA
Oncogene; 1994 Aug; 9(8):2399-403. PubMed ID: 8036024
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens.
Israël N; Hazan U; Alcami J; Munier A; Arenzana-Seisdedos F; Bachelerie F; Israël A; Virelizier JL
J Immunol; 1989 Dec; 143(12):3956-60. PubMed ID: 2574206
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the response to T-cell activation by integrated HIV-1 and HTLV-1 LTR-lacZ vectors.
Copeland KF; Hendrikx PJ; Haaksma AG; Fiering S; Van Lier R; Goudsmit J; Heeney JL
Virology; 1995 Jun; 209(2):633-6. PubMed ID: 7778294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
